Why the study?
Understanding of coronary microvascular disease pathophysiological mechanisms is very limited due to high concealment and many etiologies, which greatly limits its clinical diagnosis and treatment.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
CMEC dysfunction may underlie coronary microvascular disease; leaves open targeted therapies pending mechanistic validation.
Coronary microvascular disease is a high-risk factor for many cardiovascular events. However, due to its high concealment and many etiologies, the current understanding of its pathophysiological mechanism is very limited, which greatly limits its clinical diagnosis and treatment. In the process of the occurrence and development of coronary microvascular disease, the damage of coronary microvascular endothelial cell (CMEC) is the core link. CMEC's stress, metabolism, inflammation and other dysfunctions have a causal relationship with coronary microvascular disease, and are also the main features of coronary microvascular disease in the early stage. This article mainly reviews the molecular mechanisms of CMEC damage.
No takes yet. Share an insight, caveat, or question.
Jianying Deng (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: